Notice of NHGRI Participation in PAR-20-039, Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed)

Notice Number: NOT-HG-20-025

Key Dates
Release Date: March 13, 2020

Related Announcements

PAR-20-040

PAR-20-041

PAR-20-039

Issued by
National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Human Genome Research Institute (NHGRI) is participating in PAR-20-039 Support of Competitive Research (SCORE) Research Advancement Award (SC1 Clinical Trial Not Allowed) .

The following sections have been updated to reflect the participation of NHGRI in this FOA:

Part 1. Overview Information

Components of Participating Organizations

National Institute of General Medical Sciences (NIGMS)
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Environmental Health Sciences ( NIEHS )
National Heart, Lung and Blood Institute ( NHLBI )

National Institute on Drug Abuse (NIDA)

National Human Genome Research Institute (NHGRI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.859; 93.866; 93.853; 93.855; 93.847; 93.121; 93.173, 93.113, 93.233, 93.837, 93.838, 93.839, 93.840; 93.279; 93.172.

Scientific/Research Contact(s)

Luis A. Cubano, Ph.D.
National Human Genome Research Institute
Phone: 301-480-3435
Email: [email protected]

Financial/Grants Management Contact(s)

Deanna Ingersoll
Phone: 301-435-7858
Email:[email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Luis A. Cubano, Ph.D.
National Human Genome Research Institute
Phone: 301-480-3435
Email: [email protected]